Try our Advanced Search for more refined results
June 18, 2020
In re Chembio Diagnostics, Inc. Securities Litigation
Case Number:
2:20-cv-02706
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Block & Leviton
- Glancy Prongay
- Honigman LLP
- Kaplan Fox
- K&L Gates
- Latham & Watkins
- Levi & Korsinsky
- Pomerantz LLP
- Robbins Geller
- Rolnick Kramer
Companies
- Chembio Diagnostics Inc.
- Dougherty & Company LLC
- Municipal Employees' Retirement System of Michigan
- Robert W. Baird & Co. Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 25, 2023
COVID-19 Test Maker Investors Seek Final OK For $8.1M Deal
Investors in Chembio Diagnostics Inc., a company that sold now-revoked COVID-19 tests, have asked a New York federal court to give a final OK to an $8.1 million deal to end a lawsuit alleging that shareholders were harmed when the company's tests were taken off the market after being deemed ineffective by the U.S. Food and Drug Administration.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login